- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03783234
Triage Assessment and NEWS-score as Risk Predictor in Older Frailty Adults in the ED
January 29, 2022 updated by: Janne Alakare, Helsinki University Central Hospital
3-level Triage Assessment and National Early Warning Score as Predictor for Mortality, Hospital Admission and ED Readmission for Older Frailty Patients in the ED
Emergency Department Triage Systems have not been shown to sufficiently recognize frail elderly patients in need of urgent assessment and care.
In this prospective, observational study the performance of the 3-level triage system and the National Early Warning Score (NEWS) 2 are assessed (separately and combined) for predicting adverse outcomes in older frailty patients visiting in the ED.
Observational data for this study is gathered as part of GAOPS - main study (ClinicalTrials.gov
Identifier: NCT03751319).
Study Overview
Study Type
Observational
Enrollment (Actual)
1711
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Espoo, Finland, 02740
- Helsinki University Central Hospital, Jorvi
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
75 years and older (Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Residents of aforementioned counties, aged over 75 years, who attend the Emergency department and have clinical frailty scale minimum 4.
Description
Inclusion Criteria:
- "Clinical Frailty Scale" minimum 4 estimated at the arrival to the ED by nurse
Exclusion Criteria:
• Non-resident of the counties (City of Espoo, Kirkkonummi, Kauniainen) of the hospital district.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Older Adult Patients
ED patients age of ≥ 75 who have nurse assessed Clinical Frailty Scale ≥ 4.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mortality
Time Frame: 30 days
|
Mortality during the 30 day follow-up
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hospital admission
Time Frame: Day 0
|
Admission to hospital from the Emergency Department
|
Day 0
|
ICU/HDU admission
Time Frame: Day 0
|
Admission to the Intensive Care Unit or High Dependency Unit from the Emergency Department
|
Day 0
|
Readmission in the ED
Time Frame: Hour 72, Day 30
|
Re-visits to the ED after the index-visit
|
Hour 72, Day 30
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Veli-Pekka Harjola, Department of Emergency Medicine and Services, Helsinki University Hospital
- Principal Investigator: Janne Alakare, MD, Department of Emergency Medicine and Services, Helsinki University Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 11, 2018
Primary Completion (Actual)
September 1, 2019
Study Completion (Actual)
October 28, 2020
Study Registration Dates
First Submitted
December 19, 2018
First Submitted That Met QC Criteria
December 19, 2018
First Posted (Actual)
December 20, 2018
Study Record Updates
Last Update Posted (Actual)
February 1, 2022
Last Update Submitted That Met QC Criteria
January 29, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUS/278/2018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Frailty
-
University of PennsylvaniaCompleted
-
Instituto Tecnologico y de Estudios Superiores...Not yet recruiting
-
Longeveron Inc.CompletedAging FrailtyUnited States
-
Longeveron Inc.CompletedAging FrailtyUnited States
-
The Hong Kong Polytechnic UniversityCompleted
-
Xijing HospitalUnknownFrailty SyndromeChina
-
Region ZealandUniversity of Southern DenmarkActive, not recruitingFrailty SyndromeDenmark
-
Neurological Associates of West Los AngelesEnrolling by invitation
-
IRCCS Centro San Giovanni di Dio FatebenefratelliCompleted
-
University of Erlangen-Nürnberg Medical SchoolCompleted